Feeds:
Posts
Comments

Posts Tagged ‘armodafinil’

The AP (3/17) reported that Cephalon announced Tuesday “that patients taking Nuvigil (armodafinil) along with mood stabilizers in an eight-week midstage study showed improvement in depression symptoms. The drug, which is already approved to treat narcolepsy, was also well-tolerated by patients.” In the study, side effects “included mania, hypomania, depression, and suicidal thoughts, but were comparable with patients taking placebo. Restlessness and anxiety were also side effects experienced by the Nuvigil group.” Now, Cephalon “plans on moving the drug along to late-stage trials, which are larger in scale, to further test the drug’s effectiveness in treating bipolar disorder.”

Read Full Post »